Safety and Efficacy of a Bausch & Lomb Multipurpose Solution When Compared to Ciba Vision Aquify Multipurpose Solution
1 other identifier
interventional
541
1 country
1
Brief Summary
To the safety and efficacy of a Bausch \& Lomb Multipurpose Solution when compared to Ciba vision Aquify Multipurpose solution
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2008
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2008
CompletedFirst Submitted
Initial submission to the registry
March 7, 2008
CompletedFirst Posted
Study publicly available on registry
March 14, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2008
CompletedResults Posted
Study results publicly available
April 8, 2011
CompletedMarch 24, 2015
March 1, 2015
5 months
March 7, 2008
February 3, 2011
March 4, 2015
Conditions
Outcome Measures
Primary Outcomes (3)
Slit-lamp Findings > Grade 2
eyes with any slit lamp findings greater than Grade 2 at any visit. Slit lamp findings for each eye will be graded for severity on a scale from 0 (No Finding) to 4 (Severe Finding). Epithelial edema, epithelial microcysts, corneal staining, limbal injection, bulbar injection, superior tarsal conjunctival abnormalities, corneal neovascularization, and corneal infiltrates will be assessed.
Over 4 visits for 3 month period
Subjective Responses to Comfort Related Symptoms/Complaints
Subject symptoms/complaints will be assessed on a scale from 0 to 100, with 0 denoting unfavorable symptoms/complaints.
Over 4 visits for the 3 month period
Contact Lens Deposits
Lens deposits assessed at each follow-up visit. Degree of deposits assessed as none, light, medium, or heavy.
At each visit for 3 months
Study Arms (3)
Multipurpose Solution - Rub Care
EXPERIMENTALBausch \& Lomb Multipurpose Solution for use with contact lens care
Multipurpose Solution - No Rub Care
EXPERIMENTALBausch \& Lomb Multipurpose Solution for use with contact lens care
Ciba Vision Aquify Multipurpose Solution
ACTIVE COMPARATORCiba Vision Aquify Multipurpose Solution for use with contact lens care
Interventions
Daily care for contact lenses - rub care regimen
Daily care for contact lenses - no rub care regimen
daily care for contact lenses
Eligibility Criteria
You may qualify if:
- subject is a habitual wearer of a silicone hydrogel or group IV contact lens
- VA correctable to 0.3 LogMar or better (driving vision)
- Clear central cornea
- Subject uses a lens care system on a regular basis
You may not qualify if:
- Systemic disease affecting ocular health
- Using systemic or topical medications
- wear monovision, multifocal or toric contact lenses
- Any grade 2 or greater slit lamp findings
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Place Eye Care
Le Roy, New York, 14482, United States
Results Point of Contact
- Title
- Robert Steffen
- Organization
- Bausch & Lomb
Study Officials
- STUDY DIRECTOR
Mohinder Merchea, OD, PhD
Bausch & Lomb Incorporated
Publication Agreements
- PI is Sponsor Employee
- No
- Restriction Type
- OTHER
- Restrictive Agreement
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 7, 2008
First Posted
March 14, 2008
Study Start
March 1, 2008
Primary Completion
August 1, 2008
Study Completion
August 1, 2008
Last Updated
March 24, 2015
Results First Posted
April 8, 2011
Record last verified: 2015-03